Pilot Feasibility Study of the Safety and Efficacy of Anakinra in Heart Failure With Preserved Ejection Fraction
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
This will be a randomized, double-blind, crossover pilot study to measure the safety and
feasibility of Interleukin-1 (IL-1) blockade with Anakinra in patients with stable heart
failure with preserved ejection fraction.